Apolipoprotein E genotype in the prediction of cognitive decline and dementia in a prospectively studied elderly population

Dementia and Geriatric Cognitive Disorders

Volumn 7, Issue 3, 1996, Pages 169-174

  Brayne, C ^a   Harrington, C R ^a   Wischik, C M ^a   Huppert, F A ^a   Chi, L Y ^a   Xuereb, J H ^b   O'connor D W ^c   Paykel, E S ^a  

^a MEDICAL RESEARCH COUNCIL   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c MONASH UNIVERSITY   (Australia)

Author keywords

Alzheimer s disease; Apolipoprotein E; Cognitive decline; Elderly; Prospective study

Indexed keywords

APOLIPOPROTEIN E;

AGED; ALLELE; ALZHEIMER DISEASE; ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENETIC HETEROGENEITY; GENOTYPE; HOMOZYGOSITY; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PREDICTION; PRIORITY JOURNAL;

AGED; AGING; ALLELES; ALZHEIMER DISEASE; APOLIPOPROTEINS E; COGNITION; COGNITION DISORDERS; DEMENTIA; FEMALE; FORECASTING; GENOTYPE; HUMANS; MALE; PROSPECTIVE STUDIES;

EID: 0029866167     PISSN: 14208008     EISSN: 14219824     Source Type: Journal    
DOI: 10.1159/000106873     Document Type: Article

References (37)

1. Goate A, Chartier-Harlin MC, Mullan M, Brown J, Crawford F, Fidani L, Giuffra L, Haynes A, Irving N, James L, Manl R, Newton P, Rooke K, Roques P, Talbot C, Pericak-Vancc M, Roses A, Williamson R, Rossor M, Owen M, Hardy J: Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature 1991:349:704-706.
2. Ashall F, Goate AM: Role of the 3-amyloid precursor protein in Alzheimer's disease. Trends Biochem Sci 1994; 19:42-46.
3. Sherrington R, Rogacv EI, Liang Y, Rogacva EA, Levesque G, Ikeda M, Chi H, Lin C, Li G, Holman K, Tsuda T, Mar L, Foncin JF, Bruni AC, Montesi MP, Sorbi S, Raincro I, Pincssi L, Nee L, Chumakov I, Pollen D, Brookes A, Sanseau P, Polinskv RJ, Wasco W, DaSilva HAR, Haines JL, Pericak-Vance MA, Tanzi RE, Roses AD, Fraser PE, Romnens JM, St George-Hyslop PH: Cloning of a gene bearing missense mutations in carly-onsct familial Alzheimer’s disease. Nature 1995;375:754-760.
4. Levy-Lehad E, Wasco W, Poorkaj P, Romano DM, Oshima J, Pettingell WH, Yu CE, Jondro PD, Schmidt SD, Wang K, Crowley AC, Fu YH, Guenetle SY, Galas D, Nemens E, Wijsman EM, Bird TD, Schellenberg GD, Tanzi RE: Candidate gene for the chromosome I familial Alzheimer’s disease locus. Science 1995:269:973-977.
5. Sirittmatter WJ, Saunders AM, Schmechel D, Pericak-Vance M, Enghild J, Salvesen GS, Roses AD: Apolipoprotein E: High avidity binding to β-amyloid and increased frequency of type 4 allele in lale-onset familial Alzheimer disease. Proc Natl Acad Sci USA 1993:90: 1977-1981.
6. Sirittmatter WJ, Roses AD: Apolipoprotein F. and Alzheimer disease. Proc Natl Acad Sci USA 1995:92:4725-4727.
7. Katzman R: Apolipoprotein E and Alzheimer's disease. Curr Opinion Neurobiol 1994:4:703-707.
8. Corder EH, Saunders AM, Risch NJ, Strittmatter WJ, Schmechel DE, Gaskell PC Jr., Rirnm-Icr JB, Lockc PA, Conncally PM, Schmader KA, Small GW, Roses AD, Haines JL, Pericak-Vance MA: Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease. Nat Genet 1994;7:180-183.
9. Talbot C, London C, Craddock N, Shears S, Morris JC, Goate A: Protection against Alzheimer's disease with apoE e2. Lancet 1994: 343:1432-1433.
10. West HL, Rebeck GW, Hyman BT: Frequency of the apolipoprotein E s2 allele is diminished in sporadic Alzheimer disease. Ncurosci Lett 1994;175:46-48.
11. Maestre G, Oilman R, Stem Y, Gurland B, Chun M, Tang MX, Shelanski M, Tycko B, Mayeux R: Apolipoprotein E and Alzheimer's disease: Ethnic variation in genotypic risk. Ann Neurol 1995:37:254-259.
12. Schächter F, Faurc-Delanef L, Guénot F, Rouger H, Froguel P, Lesueur-Ginot L, Cohen D: Genetic associations with human longevity at the apoE and ACE loci. Nat Genet 1994:6: 29-32.
13. Davignon J, Gregg RE, Sing CF: Apolipoprotein E polymorphism and atherosclerosis. Arteriosclerosis 1988:8:1-21.
14. Noguchi S, Murukami K, Yamada N: Apolipoprotein E genotype and Alzheimer’s disease. Lancet 1993:342:737.
15. Frisoni GB, Calabresi L, Ceroidi C, Bianchetti A, D'Acquarica AL, Govoni S, Sirtori CR, Trabucchi M, Franceschini G: Apolipoprotein E e4 allele in Alzheimer's disease and vascular dementia. Dementia 1994.5:240-242.
16. Benjamin R, Leake A, Edwardson JA, McKeith IG, Ince PG, Perry RH, Morris CM: Apolipoprotein E genes in Lewv body and Parkinson's disease. Lancet 1994:343:1565.
17. St Clair D, Norrman J, Pern R, Yates C, Wilcock G, Brookes A: Apolipoprotein E e4 allele frequency in patients with Lewy body dementia, Alzheimer's disease and age-matched controls. Neurosci Lett 1994:176:45-46.
18. Harrington CR, Louwagie J, Rossau R, Vanmechelen E, Perry RH, Perry EK, Xuereb JH, Roth M, Wischik CM: Influence of apolipoprotein E genotype on senile dementia of the Alzheimer and Lewy body types: Significance for etiological theories of Alzheimer's disease. Am J Pathol 1994:145:1472-1484.
19. Galasko D, Saitoh T, Xia Y, Thal LJ, Katzman R, Hill LR, Hansen L: The apolipoprotcin E allele e4 is overrepresented in patients with the Lewy body variant of Alzheimer's disease. Neurology 1994:44:1950-1951.
20. Wisniewski T, Frangione B: Apolipoprotein E: A pathological chaperone protein in patients with cerebral and systemic amyloid. Neurosci Lett 1992;135:235-238.
21. Strittmatter WJ, Wcisgraber KH, Huang DY, Dong LM, Salvesen GS, Pericak-Vancc M, Schmechel D, Saunders AM, Goldgaber D, Roses AD: Binding of human apolipoprotein E to synthetic amyloid β peptide: Isoform-spc-cific effects and implications for late-onset Alzheimer disease. Proc Natl Acad Sci USA 1993; 90:8098-8102.
22. Strittmatter WJ, Weisgraber KH, Goedert M, Saunders AM, Huang D, Corder EH, Dong LM, Jakes R, Alberts MJ, Gilbert JR, Han SH, Hulette C, Einstein G, Schmechel DE, Pericak-Vance MA, Roses AD: Hypothesis: Microtu-bulc instability and paired helical filament formation in the Alzheimer disease brain are related to apolipoprotcin E genotype. Exp Neurol 1994;125:163-171.
23. Rocca WA, Hofman A, Brayne C, Bretcler MBB, Clarke M, Copeland JRM, Dartigucs JF, Engcdal K, Hagnell O, Heeren TJ, Jonker C, Lindesav J, Lobo A, Mann AH, Mölsa PK, Morgan K, O'Connor DW, Da Silva Droux A, Sulkava R, Kay DWK, Amaducci L: Frequency and distribution of Alzheimer's disease in Europe: A collaborative study of 1980-1990 prevalence findings. Ann Neurol 1991:30:381-390.
24. O’Connor DW, Pollitt PA, Hyde JB, Fellow JL, Miller ND, Brook CPB, Reiss BB, Roth M: The prevalence of dementia as measured by the Cambridge Mental Disorders of the Elderly examination. Acta Psychiatr Scand 1989;79: 190-198.
25. Paykcl ES, Brayne C, Huppcrt FA, Gill C, Barkley C, Gchlaar E, Beardsall L, Girling DM, Pollitt P, O'Connor D: Incidence of dementia in a population older than 75 years in the United Kingdom. Arch Gen Psychiatry 1994; 51:325-332.
26. Brayne C, Gill C, Huppcrt FA, Barkley C, Gehlaar E, Girling DM, O’Connor DW, Paykel ES: Incidences of clinically diagnosed subtypes of dementia in an elderly population: Cambridge project for later life. Br J Psychiatry 1995; 167: 255-262.
27. Folstein MF, Folstein SE, McHugh PR: Minimental state: A practical method for grading the cognitive stage in patients for the clinician. J Psychiatr Res 1975;12:189-198.
28. Roth M, Tym E. Mountjoy CQ, Huppert FA, Hendric H, Verma S, Goddard R: CAMDEX: A standardised instrument for the diagnosis of mental disorder in the elderly with special reference to the early detection of dementia. Br J Psychiatry 1986;149:698-709.
29. Beardsall L, Barkley C, O’Sullivan A: The response of elderly community residents to request for brain donation: An interim report. Int J Geriatr Psychiatry 1991;7:199-202.
30. Brayne C, Calloway P: The case identification of dementia in the community: A comparison of methods. Int J Geriatr Psychiatry 1990;5: 309-316.
31. Feskens EJM, Havekcs LM, Kalmijn S, DcKnijl TP, Launcr LJ, Kromhout D: Apolipoprotein s4 allele and cognitive decline in elderly men. Br Med J 1994;309:1202-1206.
32. Kuusisto J, Koivisto K, Kervinen K, Mykkanen L, Hclkala EL, Vanhanen M, Hanninen T, Pyorala K, Kesaniemi YA, Rickkinen P, Laakso M: Association of apolipoprotein E phenotypes with late onset Alzheimer's disease: Population based study. Br Med J 1994;309:636-638.
33. Petersen RC, Smith GE, Ivnik RJ, Tangalos EG, Schaid DJ, Thibodeau SN, Waring SC, Kurland LT: Apolipoprotein E status as a predictor of the development of Alzheimer's disease in memory-impaired individuals. J Am Med Assoc 1995:273:1273-1278.
34. Ilelkala EL, Koivisto K, Hanninen T, Vanhancn M, Kcrvinen K, Kuusisto J, Mykkanen L, Kesaniemi YA, Iaakso M, Riekkinen P Sr.,: The association of apolipoprotcin E polymorphism with memory: A population based study. Neurosci Lett 1995;191:141-144.
35. Kamboh MI: Apolipoprotcin E Polymorphism and susceptibility to Alzheimer’s disease. Hum Biol 1995:67:195-215.
36. Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC Jr., Rimmler JB, Locke PA, Conneally PM, Schmader KE, Tanzi RE, Gusclla JF, Small GW, Roses AD, Pcricak-Vancc MA, Haines JL: Apolipoprotein E, survival in Alzheimer's disease patients and the competing risks of death and Alzheimer’s disease. Neurology 1995;45:1323-1328.
37. Roses AD: Apolipoprotein E genotyping in the differential diagnosis, not prediction of Alzheimer’s disease. Ann Neurol 1995,38:6-14.